ReviewJournal of clinical medicine2023
Radiofrequency Ablation for Adenomyosis.
Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 25 citations in OpenAlex.
- Feasibility, safety, and short-term efficacy of ultrasound-guided radiofrequency ablation for abdominal wall endometriosis: preliminary results from a single center.Abdominal radiology (New York) · 2026Article
- Ultrasound-guided radiofrequency ablation of an intramural fibroid in a woman desiring fertility with coexisting focal adenomyosis: a case report.AJOG global reports · 2026Article
- Postpartum Management of Placenta Accreta with Transcervical Radiofrequency Ablation for Fertility Conservation.Journal of clinical medicine · 2026Article
- Magnetic resonance-guided focused ultrasound surgery for adenomyosis: current evidence and future directions.Frontiers in medicine · 2026Review
- Successful treatment of large adenomyosis with transcervical radiofrequency ablation in a high-risk patient: A case report and short review.Radiology case reports · 2025Article
- Novel Minimally Invasive Surgical Approaches to Endometriosis and Adenomyosis: A Comprehensive Review.Journal of clinical medicine · 2024Review
- Advances in Adenomyosis Treatment: High-Intensity Focused Ultrasound, Percutaneous Microwave Therapy, and Radiofrequency Ablation.Journal of clinical medicine · 2024Review
- From Diagnosis to Fertility: Optimizing Treatment of Adenomyosis for Reproductive Health.Journal of clinical medicine · 2024Review
- Adenomyosis-A Call for Awareness, Early Detection, and Effective Treatment Strategies: A Narrative Review.Healthcare (Basel, Switzerland) · 2024Review
- Radiofrequency Ablation: A Promising Treatment Method for Abdominal Wall Endometriosis.Cardiovascular and interventional radiology · 2024Article
- Intrauterine chilled saline instillation reduces endometrial impairment on MRI after ultrasound-guided percutaneous microwave ablation of uterine adenomyosis.Insights into imaging · 2024Article
- Abnormal uterine bleeding: The well-known and the hidden face.Journal of endometriosis and uterine disorders · 2024Article
- The Impact of Conservative Surgical Treatment of Adenomyosis on Fertility and Perinatal Outcomes.Journal of clinical medicine · 2024Review
- Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis.Journal of ovarian research · 2024Article
- Effects of pretreatment strategies on fertility outcomes in patients with adenomyosis.Frontiers in reproductive health · 2024Review
- Could Transcervical Radiofrequency Ablation Become a Therapy Option for Focal Adenomyosis?In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenomyosis is a common benign gynecologic condition characterized by ectopic endometrial glands and stroma in the myometrium causing pain (dysmenorrhea) and abnormal uterine bleeding. New interventional techniques have been introduced over recent years. This study evaluates the treatment success and side effects of radiofrequency ablation. An electronic literature search in the PubMed, Scopus, and ScienceDirect databases was carried out on the outcomes of pain reduction and, secondarily, on abnormal uterine bleeding, reintervention, reproductive outcome, imaging outcome, and complications. There was a mean decrease in dysmenorrhea pain scores by -63.4 ± 9.0% at 12 months. Data on other outcome parameters were sparse. No major complications were reported. Radiofrequency ablation represents a promising minimally invasive and organ-preserving treatment in patients with symptomatic adenomyosis. It is associated with clinically meaningful improvement of adenomyosis-related pain in the short term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.